Literature DB >> 8824059

Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients.

L Kroll1, R Harrington, D Jayson, J Fraser, S Gowers.   

Abstract

OBJECTIVE: To determine whether continuation of cognitive-behavioral therapy (CBT-C) could prevent relapse in adolescent psychiatric patients who had remitted from major depressive disorder (MDD).
METHOD: Seventeen patients who continued to have CBT-C for 6 months after remission from MDD were compared with a historical control group of 12 cases who had no further treatment after remission.
RESULTS: Only 1 of the 17 cases who continued with CBT-C dropped out. The cumulative relapse risk during CBT-C was significantly lower (0.2) than it had been in the historical control group (0.5).
CONCLUSIONS: CBT-C warrants further investigation in a randomized, controlled trial.

Entities:  

Mesh:

Year:  1996        PMID: 8824059     DOI: 10.1097/00004583-199609000-00013

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  20 in total

1.  Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth.

Authors:  Beth D Kennard; Sunita M Stewart; Jennifer L Hughes; Robin B Jarrett; Graham J Emslie
Journal:  Cogn Behav Pract       Date:  2008-11-01

Review 2.  Continuation and maintenance therapy of early-onset major depressive disorder.

Authors:  Graham J Emslie; Taryn L Mayes; Maryse Ruberu
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Prevention of depression in at-risk adolescents: longer-term effects.

Authors:  William R Beardslee; David A Brent; V Robin Weersing; Gregory N Clarke; Giovanna Porta; Steven D Hollon; Tracy R G Gladstone; Robert Gallop; Frances L Lynch; Satish Iyengar; Lynn DeBar; Judy Garber
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

4.  Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.

Authors:  Graham J Emslie; Taryn Mayes; Giovanna Porta; Benedetto Vitiello; Greg Clarke; Karen Dineen Wagner; Joan Rosenbaum Asarnow; Anthony Spirito; Boris Birmaher; Neal Ryan; Betsy Kennard; Lynn DeBar; James McCracken; Michael Strober; Matthew Onorato; Jamie Zelazny; Marty Keller; Satish Iyengar; David Brent
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

5.  Effectiveness of Day Treatment for Disruptive Behaviour Disorders: What is the Long-term Clinical Outcome for Children?

Authors:  Sharon E Clark; Susan Jerrott
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2012-08

Review 6.  A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents.

Authors:  J Renaud; D Axelson; B Birmaher
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 7.  Psychopharmacologic treatment of pediatric major depressive disorder.

Authors:  Khrista Boylan; Soledad Romero; Boris Birmaher
Journal:  Psychopharmacology (Berl)       Date:  2006-08-08       Impact factor: 4.530

8.  Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder.

Authors:  R Harrington; J Whittaker; P Shoebridge; F Campbell
Journal:  BMJ       Date:  1998-05-23

9.  Preventing depression: a randomized trial of interpersonal psychotherapy-adolescent skills training.

Authors:  Jami F Young; Laura Mufson; Robert Gallop
Journal:  Depress Anxiety       Date:  2010-05       Impact factor: 6.505

10.  Sequential treatment with fluoxetine and relapse--prevention CBT to improve outcomes in pediatric depression.

Authors:  Betsy D Kennard; Graham J Emslie; Taryn L Mayes; Paul A Nakonezny; Jessica M Jones; Aleksandra A Foxwell; Jessica King
Journal:  Am J Psychiatry       Date:  2014-10       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.